Bristol-Myers Squibb Company (BMY) vs Johnson & Johnson (JNJ)
A side-by-side comparison of Bristol-Myers Squibb Company and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
BMY
Bristol-Myers Squibb Company
$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
JNJ
Johnson & Johnson
$265.58HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — BMY vs JNJ
growth of $100 · dividends reinvested · last 10yBMY +64.7% (+5.1%/yr)JNJ +197.0% (+11.5%/yr)JNJ compounded faster over this window
BMY JNJ
BMY vs JNJ: by the numbers
- •JNJ is the larger company ($640.02B vs $130.00B market cap).
- •BMY trades at the lower trailing earnings multiple (14.02 vs 30.77 P/E), one valuation lens rather than an overall verdict.
- •JNJ converts more revenue to profit (21.48% vs 18.87% net margin).
- •JNJ grew revenue faster over the past five years (2.93% vs 2.08% CAGR).
- •BMY pays the higher dividend yield (3.94% vs 1.98%).
Metrics side by side
Valuation
| Metric | BMY | JNJ |
|---|---|---|
| P/E ratio | 14.02 | 30.77 |
| Forward P/E | 9.18 | 22.93 |
| P/S ratio | 2.64 | 6.54 |
| P/B ratio | 5.82 | 7.53 |
| EV / EBITDA | 9.71 | 19.66 |
| FCF yield | 8.80% | 2.92% |
Profitability
| Metric | BMY | JNJ |
|---|---|---|
| Gross margin | 70.16% | 70.45% |
| Operating margin | 28.27% | 26.81% |
| Net margin | 18.87% | 21.48% |
| ROE | 41.59% | 24.76% |
| ROIC | 15.47% | 13.89% |
Dividends
| Metric | BMY | JNJ |
|---|---|---|
| Dividend yield | 3.94% | 1.98% |
| Payout ratio | 55.29% | 61.18% |
Growth (annualized)
| Metric | BMY | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 2.08% | 2.93% |
| EPS CAGR (5Y) | 9.38% | 14.61% |
| FCF CAGR (5Y) | -0.95% | -2.05% |
| Total return CAGR (5Y) | 4.39% | 12.90% |
Frequently asked
- Which has the lower trailing P/E, BMY or JNJ?
- BMY has the lower trailing P/E: BMY trades at 14.02 and JNJ at 30.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BMY or JNJ?
- Over the past five years, JNJ grew revenue faster — BMY at a 2.08% CAGR versus JNJ at 2.93%.
- Does BMY or JNJ pay a bigger dividend?
- BMY yields 3.94% and JNJ yields 1.98% based on trailing dividends and the latest price.
- Is BMY or JNJ more profitable?
- JNJ runs the higher net margin — BMY at 18.87% versus JNJ at 21.48%.
- How have BMY and JNJ total returns compared?
- Over the past 10 years, BMY delivered 5.01% and JNJ delivered 11.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioJohnson & Johnson P/E ratioBristol-Myers Squibb dividend yieldJohnson & Johnson dividend yieldBristol-Myers Squibb ROEJohnson & Johnson ROEBristol-Myers Squibb operating marginJohnson & Johnson operating marginBristol-Myers Squibb revenue growthJohnson & Johnson revenue growthBristol-Myers Squibb free cash flowJohnson & Johnson free cash flow
Bristol-Myers Squibb & Johnson & Johnson appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.